<DOC>
	<DOCNO>NCT00807690</DOCNO>
	<brief_summary>BACKGROUND Vitiligo common , often distress condition . Many patient achieve sufficient effect regard treatment choice present , narrow band ( NB ) UVB ( Tl01 ) . There report patient partly successfully treat Tacrolimus ointment . AIM OF THE STUDY We want study whether Tacrolimus ointment may give additive effect symmetric vitiligo combination NB-UVB . METHODS This double blind left/right comparative study 6 month treatment time . Patients treated whole body NB-UVB x 2 x 3 weekly , addition Tacrolimus ointment versus placebo every night affect half body sit . To measure effect use photodocumentation addition morphometric registration symmetric target lesion every 6 week .</brief_summary>
	<brief_title>Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo</brief_title>
	<detailed_description />
	<mesh_term>Vitiligo</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patients age least 18 year stable , symmetric vitiligo Patients segmental vitiligo , age &lt; 18 year , know hypersensitivity Tacrolimus , pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>vitiligo</keyword>
	<keyword>tacrolimus ointment 0.1 %</keyword>
	<keyword>narrowband UVB ( TL01 )</keyword>
</DOC>